Mesenchymal stem cell therapy for acute and chronic pancreatitis.

Related Articles

Mesenchymal stem cell therapy for acute and chronic pancreatitis.

J Gastroenterol. 2017 Jun 23;:

Authors: Kawakubo K, Ohnishi S, Kuwatani M, Sakamoto N

Abstract
Mesenchymal stem cells (MSCs) have attracted attention as a cell source for regenerative medicine. In particular, MSCs have an anti-inflammatory effect by secreting several kinds of bioactive molecules. MSC therapy is now being applied to various gastrointestinal diseases, such as graft-versus-host disease, inflammatory bowel disease, and liver cirrhosis. Therefore, MSC therapy has the potential to be a novel treatment for acute and chronic pancreatitis by suppressing inflammation. Several studies have investigated the effect of MSC therapy on acute and chronic pancreatitis, but the underlying mechanisms remain unknown. In this review, we summarize the present status of MSC therapy for acute and chronic pancreatitis.

PMID: 28646417 [PubMed – as supplied by publisher]

PubMed Link: https://www.ncbi.nlm.nih.gov/pubmed/28646417?dopt=Abstract